Alan Baltz

Resident Physician

UAMS

Last publication 2026 Last refreshed 2026-05-16

faculty

4 h-index 19 pubs 56 cited

Research Areas

Links

ORCID Research Group

OverviewAI-generated summary

Alan Baltz, a resident physician at the University of Arkansas for Medical Sciences, researches various aspects of cancer treatment and patient outcomes. His work includes analyzing the clinical impact of established guidelines on staging imaging for early-stage breast cancers, utilizing SEER-Medicare data to conduct time-series analyses. Baltz has also investigated the real-world survival outcomes for patients receiving CAR-T and bispecific T-cell engagers for relapsed/refractory diffuse large B-cell lymphoma. His research extends to understanding the impact of the CAR-T era on survival in this patient population through U.S. population-based cohort studies.

Further contributing to the field, Baltz's publications address the safety and effectiveness of specific drugs through systematic literature reviews, such as for Benzonatate. He also explores predictive factors for survival in certain hematological malignancies, including analyzing epidemiological and clinical trends from the Arkansas Central Cancer Registry. Baltz collaborates with researchers including Ankur Varma and Mamatha Gaddam, with whom he shares multiple publications.

Metrics

h-index: 4
Publications: 19
Citations: 56

Selected Publications

Real-World Survival Outcomes of CAR-T and Bispecific T-cell Engagers in Patients with relapsed/refractory DLBCL (2026)

DOI OpenAlex
Impact of the CAR-T era on survival in diffuse large B-cell lymphoma: A u.S. population-based cohort study (2025)

DOI OpenAlex
Can the development of drug-induced rash after mogamulizumab administration predict survival in mycosis fungoides/sezary syndrome? a trinetx-based analysis (2025)

DOI OpenAlex
Epidemiological and clinical trends in common hematological malignancies in Arkansas: Arkansas Central Cancer Registry (ACCR)-based study. (2025)

DOI OpenAlex
Impact of Social Vulnerability Index and Travel Distance on Access to Chimeric Antigen Receptor T-Cell Therapy (2024)

DOI OpenAlex
Cutaneous Involvement By Peripheral T-Cell Lymphoma: Incidence, Characteristics, Treatment Trends, and Outcomes in the United States (2000-2021) (2024)

DOI OpenAlex
Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity (2023)

25 citations DOI OpenAlex
Participation in a multidisciplinary institutional committee, “RQUEST,” to enhance quality improvement education, project design, and implementation for hematology/oncology fellows. (2023)

DOI OpenAlex
Exploring the association between medical marijuana cardholder status and antiemetic overuse. (2023)

DOI OpenAlex
Benzonatate Safety and Effectiveness: A Systematic Review of the Literature (2023)

5 citations DOI OpenAlex